Moderna says Takeda plans to recall three lots of suspended COVID-19 vaccine

  • English
  • 日本語
  • 简体字
  • 繁體字
  • Français
  • Español
  • العربية
  • Русский

FILE PHOTO: A vial containing doses of the Moderna vaccine against the coronavirus disease (COVID-19) and syringes are pictured at Japan Airlines (JAL) facility where its staff receive the vaccines at Haneda airport in Tokyo, Japan June 14, 2021. REUTERS/Kim Kyung-Hoon
FILE PHOTO: A vial containing doses of the Moderna vaccine against the coronavirus disease (COVID-19) and syringes are pictured at Japan Airlines (JAL) facility where its staff receive the vaccines at Haneda airport in Tokyo, Japan June 14, 2021. REUTERS/Kim Kyung-Hoon

(Reuters) - Moderna Inc said on Wednesday its Japanese distribution partner, Takeda Pharmaceutical Co Ltd, planned to initiate the recall of three lots of its COVID-19 vaccine that were suspended due to contamination.

Japan's health ministry said particles of stainless steel were found in suspended Moderna COVID-19 vaccines, but it did not expect they would pose an additional health risk.

(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)

(c) Copyright Thomson Reuters 2021. Click For Restrictions -
https://agency.reuters.com/en/copyright.html

Reuters Japan Health United States Asia US